Lipella Pharmaceuticals

About:

Lipella Pharmaceuticals is a biotechnology company that develops products for intravesical therapy.

Website: http://www.lipella.com

Twitter/X: LipellaPharma

Top Investors: Pittsburgh Life Sciences Greenhouse, National Institute of Diabetes and Digestive and Kidney Diseases

Description:

Lipella Pharmaceuticals is a biotechnology company that develops products for intravesical therapy. It is a method of providing local treatments directly to the urinary bladder lumen via urethral catheterization. Indications they target include interstitial cystitis (also known as painful bladder syndrome), overactive bladder, and superficial bladder cancer. Interstitial cystitis is a chronic, painful, inflammatory condition of the bladder wall that affects over 1 million people in the United States. Its cause is unknown and there is no cure. Treatment options exist, but a majority of cases are refractive to existing therapies.